[Mechanism of the action of biquanid preparations and their use in diabetes mellitus in children].
D001645:Biguanides / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D004342:Drug Hypersensitivity / Q000209:etiology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D010101:Oxygen Consumption
D001645:Biguanides; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D005947:Glucose
O mekhanizme deĭstviia biguanidnykh preparatov i primenenie ikh pri sakharnom diabete u deteĭ.